Literature DB >> 23338619

Biospectroscopy insights into the multi-stage process of cervical cancer development: probing for spectral biomarkers in cytology to distinguish grades.

Nikhil C Purandare1, Imran I Patel, Júlio Trevisan, Noel Bolger, Ronan Kelehan, Günther von Bünau, Pierre L Martin-Hirsch, Walter J Prendiville, Francis L Martin.   

Abstract

Cervical cancer screening programmes have greatly reduced the burden associated with this disease. However, conventional cervical cytology screening still lacks sensitivity and specificity. There is an urgent need for the development of a low-cost robust screening technique. By generating a spectral "biochemical-cell fingerprint", Fourier-transform infrared (FTIR) spectroscopy has been touted as a tool capable of segregating grades of dysplasia. A total of 529 specimens were collected over a period of one year at two colposcopy centres in Dublin, Ireland. Of these, n = 128 were conventionally classed as high-grade, n = 186 as low-grade and n = 215 as normal. Following FTIR spectroscopy, derived spectra were examined for segregation between classes in scores plots generated with subsequent multivariate analysis. A degree of crossover between classes was noted and this could be associated with imperfect conventional screening resulting in an inaccurate diagnosis or an incomplete transition between classes. Maximal crossover associated with n = 102 of 390 specimens analyzed was found between normal and low-grade specimens. However, robust spectral differences (P≤ 0.0001) were still observed at 1512 cm(-1), 1331 cm(-1) and 937 cm(-1). For high-grade vs. low-grade specimens, spectral differences (P≤ 0.0001) were observed at Amide I (1624 cm(-1)), Amide II (1551 cm(-1)) and asymmetric phosphate stretching vibrations (νasPO2(-); 1215 cm(-1)). Least crossover (n = 50 of 343 specimens analyzed) was seen when comparing high-grade vs. normal specimens; significant inter-class spectral differences (P≤ 0.0001) were noted at Amide II (1547 cm(-1)), 1400 cm(-1) and 995 cm(-1). Deeper understanding of the underlying changes in the transition between cervical cytology classes (normal vs. low-grade vs. high-grade) is required in order to develop biospectroscopy tools as a screening approach. This will then allow for the development of blind classification algorithms.

Entities:  

Mesh:

Year:  2013        PMID: 23338619     DOI: 10.1039/c3an36527a

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  5 in total

1.  Histology verification demonstrates that biospectroscopy analysis of cervical cytology identifies underlying disease more accurately than conventional screening: removing the confounder of discordance.

Authors:  Ketan Gajjar; Abdullah A Ahmadzai; George Valasoulis; Júlio Trevisan; Christina Founta; Maria Nasioutziki; Aristotelis Loufopoulos; Maria Kyrgiou; Sofia Melina Stasinou; Petros Karakitsos; Evangelos Paraskevaidis; Bianca Da Gama-Rose; Pierre L Martin-Hirsch; Francis L Martin
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

2.  Imaging cervical cytology with scanning near-field optical microscopy (SNOM) coupled with an IR-FEL.

Authors:  Diane E Halliwell; Camilo L M Morais; Kássio M G Lima; Julio Trevisan; Michele R F Siggel-King; Tim Craig; James Ingham; David S Martin; Kelly A Heys; Maria Kyrgiou; Anita Mitra; Evangelos Paraskevaidis; Georgios Theophilou; Pierre L Martin-Hirsch; Antonio Cricenti; Marco Luce; Peter Weightman; Francis L Martin
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

3.  Tracking the Impact of Excisional Cervical Treatment on the Cervix using Biospectroscopy.

Authors:  Diane E Halliwell; Maria Kyrgiou; Anita Mitra; Ilkka Kalliala; Evangelos Paraskevaidis; Georgios Theophilou; Pierre L Martin-Hirsch; Francis L Martin
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

4.  An imaging dataset of cervical cells using scanning near-field optical microscopy coupled to an infrared free electron laser.

Authors:  Diane E Halliwell; Camilo L M Morais; Kássio M G Lima; Júlio Trevisan; Michele R F Siggel-King; Tim Craig; James Ingham; David S Martin; Kelly Heys; Maria Kyrgiou; Anita Mitra; Evangelos Paraskevaidis; Georgios Theophilou; Pierre L Martin-Hirsch; Antonio Cricenti; Marco Luce; Peter Weightman; Francis L Martin
Journal:  Sci Data       Date:  2017-07-11       Impact factor: 6.444

5.  Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines.

Authors:  Huijiang Zhou; Jiangfeng Xu; Shuai Wang; Jinfeng Peng
Journal:  Mol Med Rep       Date:  2018-04-05       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.